Medivir AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	1,018	184	319	159	552	624
Market Cap Growth	446.78%	-42.39%	100.21%	-71.16%	-11.61%	209.74%
Enterprise Value	875	167	236	110	424	411
Last Close Price	1.89	0.41	2.84	2.85	8.11	9.18
PS Ratio	113.05	21.57	91.43	20.85	125.15	19.27
PB Ratio	5.33	1.18	2.76	0.73	2.86	2.22
P/TBV Ratio	5.33	1.18	2.76	0.73	2.86	2.22
EV/Sales Ratio	97.20	19.60	67.61	14.40	96.27	12.69
Debt / Equity Ratio	0.03	0.05	0.10	0.06	0.08	0.05
Net Debt / Equity Ratio	-0.75	-0.71	-0.44	-0.72	-0.53	-0.74
Net Debt / EBITDA Ratio	1.61	1.19	0.40	1.68	1.15	3.23
Net Debt / FCF Ratio	2.40	1.51	0.41	2.61	1.00	4.25
Asset Turnover	0.05	0.05	0.02	0.03	0.02	0.12
Quick Ratio	5.34	3.64	1.36	3.03	4.37	5.40
Current Ratio	5.34	3.66	1.38	3.05	4.39	5.42
Return on Equity (ROE)	-61.65%	-69.74%	-73.97%	-43.50%	-37.46%	-29.84%
Return on Assets (ROA)	-30.06%	-31.43%	-34.76%	-22.21%	-19.43%	-15.27%
Return on Invested Capital (ROIC)	-191.97%	-171.45%	-203.28%	-121.40%	-107.49%	-79.32%
Return on Capital Employed (ROCE)	-45.10%	-56.90%	-103.20%	-40.50%	-43.00%	-21.90%
Earnings Yield	-8.89%	-51.44%	-38.71%	-56.14%	-16.09%	-10.11%
FCF Yield	-	-39.97%	-38.99%	-37.50%	-18.53%	-7.81%
Buyback Yield / Dilution	-104.66%	-25.08%	-88.71%	-8.44%	-5.53%	-117.45%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.